G. Vass

605 total citations
18 papers, 486 citations indexed

About

G. Vass is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, G. Vass has authored 18 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 2 papers in Surgery. Recurrent topics in G. Vass's work include Asthma and respiratory diseases (7 papers), Respiratory and Cough-Related Research (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). G. Vass is often cited by papers focused on Asthma and respiratory diseases (7 papers), Respiratory and Cough-Related Research (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). G. Vass collaborates with scholars based in Hungary, United States and United Kingdom. G. Vass's co-authors include Ildikó Horváth, Éva Huszár, Erzsébet Barát, I Herjavecz, Alun D. Hughes, Angela Haczku, S. Kierstein, István Pénzes, Márk Kollai and M. Valyon and has published in prestigious journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

G. Vass

18 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Vass Hungary	8	252	185	121	69	59	18	486
I Herjavecz Hungary	10	233 0.9×	226 1.2×	139 1.1×	48 0.7×	56 0.9×	20	427
Albert G. Driver United States	7	167 0.7×	183 1.0×	193 1.6×	11 0.2×	60 1.0×	8	427
J. S. Mann United Kingdom	6	119 0.5×	182 1.0×	116 1.0×	9 0.1×	27 0.5×	10	316
Caterina Brindicci United Kingdom	14	706 2.8×	711 3.8×	34 0.3×	35 0.5×	159 2.7×	19	943
Hendrik J. Agteresch Netherlands	9	34 0.1×	65 0.4×	227 1.9×	24 0.3×	31 0.5×	11	501
Marcel E. Van Der Straeten Belgium	10	192 0.8×	257 1.4×	33 0.3×	8 0.1×	30 0.5×	12	451
Julie Coote United Kingdom	6	164 0.7×	156 0.8×	45 0.4×	5 0.1×	20 0.3×	6	299
Christian Karcher Australia	5	39 0.2×	44 0.2×	153 1.3×	11 0.2×	54 0.9×	10	357
Marion Marlinge France	11	41 0.2×	29 0.2×	53 0.4×	38 0.6×	12 0.2×	25	309
Sandra Weber Germany	13	88 0.3×	34 0.2×	11 0.1×	24 0.3×	83 1.4×	22	405

Countries citing papers authored by G. Vass

Since Specialization

Citations

This map shows the geographic impact of G. Vass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Vass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Vass more than expected).

Fields of papers citing papers by G. Vass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Vass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Vass. The network helps show where G. Vass may publish in the future.

Co-authorship network of co-authors of G. Vass

This figure shows the co-authorship network connecting the top 25 collaborators of G. Vass. A scholar is included among the top collaborators of G. Vass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Vass. G. Vass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Vass, G., et al.. (2021). Should Newborns with Refractory Chylothorax Be Tried on Higher Dose of Octreotide?. Neonatology. 118(1). 122–126. 6 indexed citations

Laszlovszky, I., et al.. (2021). The effect of cariprazine on patient engagement: Post-hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia. European Psychiatry. 64(S1). S533–S533. 2 indexed citations

Vass, G., Ágota Barabássy, I. Laszlovszky, et al.. (2020). P.572 Safety with or without treatment: a post-hoc analysis comparing stable patients discontinuing cariprazine treatment versus patients taking cariprazine long-term. European Neuropsychopharmacology. 40. S324–S325. 1 indexed citations

Laszlovszky, I., Ágota Barabássy, B. Szatmári, et al.. (2020). P.575 Long-term functional improving effects of cariprazine: post-hoc analyses of acute and predominant negative symptom schizophrenia patient data. European Neuropsychopharmacology. 40. S326–S327. 2 indexed citations

Vass, G. & Ildikó Horváth. (2008). Adenosine and Adenosine Receptors in the Pathomechanism and Treatment of Respiratory Diseases. Current Medicinal Chemistry. 15(9). 917–922. 30 indexed citations

Vass, G., et al.. (2007). Neonatal lupus erythematosus: case report and review of the literature. Orvosi Hetilap. 148(43). 2051–2055. 1 indexed citations

Haczku, Angela, Richard Y. Cao, G. Vass, et al.. (2006). IL-4 and IL-13 Form a Negative Feedback Circuit with Surfactant Protein-D in the Allergic Airway Response. The Journal of Immunology. 176(6). 3557–3565. 73 indexed citations

Vass, G., Éva Huszár, G Baktai, et al.. (2006). The effect of allergic rhinitis on adenosine concentration in exhaled breath condensate. Clinical & Experimental Allergy. 36(6). 742–747. 22 indexed citations

Huszár, Éva, G. Vass, Zsuzsanna Szabó, et al.. (2005). Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction. European Respiratory Journal. 25(5). 873–878. 63 indexed citations

10.

Haczku, Angela, G. Vass, & S. Kierstein. (2004). Surfactant protein D and asthma. Clinical & Experimental Allergy. 34(12). 1815–1818. 12 indexed citations

11.

Vass, G., et al.. (2004). Surfactant protein (SP)-D suppresses antigenic and mitogenic T cell activation in vitro. Journal of Allergy and Clinical Immunology. 113(2). S252–S252. 4 indexed citations

12.

Vass, G., Éva Huszár, Erzsébet Barát, et al.. (2003). Comparison of Nasal and Oral Inhalation during Exhaled Breath Condensate Collection. American Journal of Respiratory and Critical Care Medicine. 167(6). 850–855. 62 indexed citations

13.

Vass, G., Éva Huszár, Erzsébet Barát, & Ildikó Horváth. (2003). [Exhaled breath condensate and its analysis--a new method in pulmonology].. PubMed. 144(51). 2517–24. 7 indexed citations

14.

Huszár, Éva, et al.. (2002). Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. European Respiratory Journal. 20(6). 1393–1398. 158 indexed citations

15.

Vass, G., et al.. (1998). How effective is the routine mediastinal blockdissection in the surgery of non-small cell lung cancer?. PubMed. 37(1-2). 85–93. 2 indexed citations

16.

Hughes, Alun D., et al.. (1982). In Vivo Platelet Activation Following Myocardial Infarction and Acute Coronary Ischaemia. Thrombosis and Haemostasis. 48(2). 133–135. 33 indexed citations

17.

Hughes, Alun D., et al.. (1979). Beta Thromboglobulin and Myocardial Infarction. Thrombosis and Haemostasis. 6 indexed citations

18.

Tănăsescu, Radu, et al.. (1968). [Evans syndrome and diabetes mellitus, sequelae of viral hepatitis].. PubMed. 105(1). 31–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact